Aptalis Pharma Inc. · Birmingham, AL United States (NASDAQ TRACE: AXCA.GF)
| 22 Inverness Center Pkwy., Ste. 310 | Phone: 205-991-8085 |
| Birmingham, AL | |
| 35242 | |
| United States | 
Map This Company |
Aptalis Pharma Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Aptalis Pharma knows its ABCs when it comes to treating CF and GI ailments. The company, formerly named Axcan Intermediate Holdings, develops and sells drugs mainly to treat cystic fibrosis (CF) and gastrointestinal (GI) conditions. Its Urso line treats liver disease; Carafate and Sulcrate treat ulcers; and Canasa and Salofalk offer relief for inflammatory bowel diseases. In addition, Aptalis Pharma markets Zenpep, a digestive aids for patients with exocrine pancreatic insufficiency, a condition associated with cystic fibrosis. The firm's products are primarily sold in North America and the European Union. Aptalis Pharma is a subsidiary of Axcan Holdings, which is controlled by
Aptalis Pharma Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Private - NASDAQ TRACE: AXCA.GF Single Location |
|---|---|
| Fiscal Year-End | September |
| 2010 Employees | 525 |
Executives
14 executives listed for Aptalis Pharma Inc.'s Birmingham, AL location.